The invention provides novel compounds of formula (I), (II), (III), and (IV). The invention also provides pharmaceutical compositions comprising such compounds as well as methods for treating diseases associated with opioid receptor function by administering such compounds to an animal in need of treatment. The invention also provides therapeutic methods for the use of compounds of formula (V), as well as methods for treating diseases by administering such compounds.
Synthesis of Salvinorin A Analogues as Opioid Receptor Probes
作者:Kevin Tidgewell、Wayne W. Harding、Anthony Lozama、Howard Cobb、Kushal Shah、Pavitra Kannan、Christina M. Dersch、Damon Parrish、Jeffrey R. Deschamps、Richard B. Rothman、Thomas E. Prisinzano
DOI:10.1021/np060094b
日期:2006.6.1
Several neoclerodanes, such as salvinorin A (1) and herkinorin (3), have recently been shown to possess opioid receptor activity in vitro and in vivo. To explore the structure-affinity relationships of this interesting class of compounds, we have synthesized a series of analogues from 1 isolated from Salvia divinorum. Here, we report the semisynthesis of neoclerodane diterpenes and their structure-affinity